N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)

Sponsor: Mirum Pharmaceuticals, Inc. • ClinicalTrials.gov ID: NCT07200908

Registry updated: 2026-10-08
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This is a Phase 3, global, randomized, open-label, multicenter, trial evaluating brelovitug (BJT-778) vs bulevirtide for the treatment of chronic hepatitis delta infection (CHD). The main goal of this study is to test the effectiveness of brelovitug compared to bulevirtide as a long-term treatment in patients with chronic HDV infection.

Interventions

  • Brelovitug 300 mg (Drug)
    Route of administration- Subcutaneous Injection
  • Bulevirtide 2 mg and Brelovitug - 300 mg (Drug)
    Route of Administration- Subcutaneous Injection

Eligibility criteria

Key Inclusion Criteria: 1. Willing and able to provide written informed consent 2. Chronic HDV infection 3. HDV RNA \>500 IU/mL at Screening 4. ALT \>ULN at Screening 5. Willing to take or already taking HBV neucleos(t)ide therapy. Key Exclusion Criteria: 1. Pregnant or nursing females 2. Unwilling to comply with contraception requirements during the study 3. Difficulty with blood collection and/or poor venous access for the purposes of phlebotomy 4. Clinical hepatic decompensation (i.e., ascites, encephalopathy variceal hemorrhage). 5. Solid organ or bone marrow transplantation 6. Presence of other liver disease(s) (non-HBV/HDV), such as nonalcoholic steatohepatitis (NASH), alcohol associated hepatitis, cholestatic liver disease, hepatocellular carcinoma. Note - Other protocol-defined Inclusion/Exclusion criteria apply.

Conditions

Chronic Hepatitis D Infection

Locations

  • Medical University of Graz — Graz, Austria
  • Universitätsklinikum St. Pölten — Sankt Pölten, Austria
  • Fakultni Nemocnice Brno — Brno, Brno, Czechia
  • Fakultni Nemocnice Hradec Kralove — Hradec Králové, Hradec Králové, Czechia
  • Krajská nemocnice Liberec, a.s. — Liberec, Liberec, Czechia
  • Institute For Clinical And Experimental Medicine — Prague, Prague, Czechia
  • Klin Med s.r.o. — Prague, Prague, Czechia
  • Hôpital Estaing — Clermont-Ferrand, France
  • Hôpital Beaujon — Clichy, France
  • University Hospital Henri Mondor - APHP — Créteil, France
  • CHU Grenoble Alpes Hopital Nord Michallon — La Tronche, France
  • Centre Hospitalier de Versailles _ Hopital Andre Magnot — Le Chesnay, France
  • Lille Regional University Hospital Centre — Lille, France
  • University Hospital Limoges — Limoges, France
  • Hôpital de la Croix-Rousse — Lyon, France
  • Hôpital Pitié Salpêtrière — Paris, France
  • Hopital Cochin — Paris, France
  • CHU de Bordeaux - Hopital Haut-Leveque — Pessac, France
  • Centre Hospitalier Universitaire De Rennes — Rennes, France
  • Hôpital Rangueil — Toulouse, France
  • Goethe University Frankfurt — Frankfurt, Frankfurt, Germany
  • Rostock University Medical Center — Rostock, Rostock, Germany
  • Universitätsklinikum Düsseldorf — Düsseldorf, Germany
  • Medizinische Hochschule Hannover — Hanover, Germany
  • ASST Papa Giovanni XXIII — Bergamo, Italy
  • Humanitas Research Hospital — Milan, Italy
  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico — Milan, Italy
  • ASST Grande Ospedale Metropolitano Niguarda — Milan, Italy
  • University of Parma — Parma, Italy
  • AOU Pisana - Cisanello — Pisa, Italy
  • National Institute of Infectious Diseases Lazzaro Spallanzani — Roma, Italy
  • Aga Khan University, Aga Khan Hospital and Medical College Foundation — Karachi, Pakistan
  • National Institute Of Infectious Diseases — Bucharest, Bucharest, Romania
  • Spitalul Clinic De Boli Infectioase Si Tropicale Dr. Victor Babes — Bucharest, Bucharest, Romania
  • Centrul Medical Unirea S.R.L — Iași, Lasi, Romania
  • National Institute of Infectious Diseases Prof Dr Matei Bals — Bucharest, Romania
  • Fundeni Clinical Institute — Bucharest, Romania
  • Spitalul Clinic de Boli Infectioase Constanta — Constanța, Romania
  • Hospital Universitario Torrecardenas — Almería, Almeria, Spain
  • Hospital Universitari Vall D Hebron — Barcelona, Barcelona, Spain
  • Hospital Clinic Provincial De Barcelona — Barcelona, Spain
  • Hospital Universitario Ramón y Cajal — Madrid, Spain
  • Hospital Universitario Virgen de la Victoria — Málaga, Spain
  • Hospital Universitario Marqués de Valdecilla — Santander, Spain
  • Hospital Universitario Álvaro Cunqueiro — Vigo, Spain
  • Karolinska University Hospital — Huddinge, Sweden
  • Hôpitaux Universitaires — Geneva, Canton of Geneva, Switzerland
  • HOCH Health Ostschweiz — Sankt Gallen, St.Gallen, Switzerland
  • Universitätsspital Zürich — Zurich, Switzerland
  • Queen Elizabeth Hospital Birmingham — Birmingham, Birmingham, United Kingdom
  • Chelsea and Westminster Hospital NHS Foundation Trust — London, London, United Kingdom
  • North Manchester General Hospital — Manchester, Manchester, United Kingdom
  • Hull University Teaching Hospitals — Cottingham, United Kingdom
  • Barts Health NHS Trust — London, United Kingdom
  • King's College Hospital NHS Foundation Trust — London, United Kingdom
  • Republican Specialized Scientific and Practical Medical Center of Epidemiology, Microbiology, Infectious and Parasitic Diseases — Fergana, Uzbekistan
  • Research Institute of Virology of the Republic of Uzbekistan — Tashkent, Uzbekistan
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record